Legend Biotech Corporatio...

NASDAQ: LEGN · Real-Time Price · USD
37.47
-0.24 (-0.64%)
At close: Aug 15, 2025, 3:59 PM
37.50
0.09%
After-hours: Aug 15, 2025, 06:06 PM EDT

Legend Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
255.95M 195.05M 186.52M 160.21M 186.52M 93.99M 79.46M 96.01M 73.33M 36.34M 27.63M 27.36M 11.97M 40.83M 38.99M 16.88M 20.23M 13.68M
Cost of Revenue
104.21M 71.34M 73.92M 55.47M 50.45M 60.46M 37.8M 43.48M 32.67M 35.61M 22.96M 25.46M 16.94M 81.35M n/a n/a n/a 71.07M
Gross Profit
151.74M 123.71M 112.6M 104.74M 136.07M 33.53M 41.66M 52.53M 40.66M 723K 4.67M 1.9M -4.97M -40.52M 38.99M 16.88M 20.23M -57.39M
Operating Income
-21.96M -50.65M -74.39M -70.05M -41.55M -117.86M -121.05M -66.99M -88.66M -106.86M 319.25M -142.76M -119.28M -74.99M -91.44M -128.04M -89.25M -79.55M
Interest Income
10.47M 12.06M 13.65M 16.63M 17.05M 13.87M 17.3M 18.42M 5.18M 6.75M 4.89M 36.5K n/a 458K 423K 321K n/a 100K
Pretax Income
-125.24M -99.13M 40.51M -120.89M -17.97M -59.79M -146.81M -62.49M -198.84M -111.97M -135.72M -84.8M -193.07M -41.09M -88.33M -125.39M -91.58M -80.9M
Net Income
-125.82M -100.92M 26.28M -125.32M -18.2M -59.79M -144.82M -62.21M -199.13M -112.1M -135.88M -84.96M -193.23M -42.08M -88.33M -125.39M -91.58M -80.9M
Selling & General & Admin
75.05M 72.43M 83.13M 79.57M 65.42M 56.15M 62.38M 49.2M 49.18M 40.16M 52.5M 42.09M 45.49M 33.96M 69.95M 31.34M 26.03M 22.16M
Research & Development
98.65M 101.92M 104.43M 95.52M 112.63M 100.96M 105.68M 95.86M 95.79M 84.89M 80.76M 104.52M 68.83M 81.35M 86.5M 72.31M 83.46M 71.07M
Other Expenses
n/a n/a -563K -306K n/a -440K -28.18M n/a n/a n/a 169K -2.4M n/a -502K -1.47M n/a -2.23M -1.31M
Operating Expenses
173.7M 174.36M 187M 174.79M 178.04M 151.39M 162.72M 144.88M 143.62M 125.05M 131.89M 145.55M 114.32M 114.8M 156.46M 103.5M 108.17M 93.23M
Interest Expense
5.24M 5.06M 5.15M 5.5M 5.48M 5.47M 5.82M 5.68M 5.18M 5.11M 4.86M 3.25M 1.64M 994K 602K 208K 52K 38K
Selling & Marketing Expenses
n/a 40.97M 48.92M 44.27M 30.06M 24.22M 33.68M 21.1M 21.43M 17.95M 25.82M 18.85M 27.44M 21.3M 52.81M 19.53M 16.78M 13.42M
Cost & Expenses
277.91M 245.7M 260.92M 230.25M 228.49M 211.85M 200.52M 188.36M 176.29M 160.66M 154.86M 171.01M 131.26M 114.8M 156.46M 103.5M 108.17M 93.23M
Income Tax Expense
584.05K 1.79M 14.23M 4.43M 226K 5K -1.99M -288K 290K 128K 153K 152K 157K 994K -3.71M -3.5M 1K 1.31M
Shares Outstanding (Basic)
92.07M 91.88M 91.43M 91.36M 91.3M 91M 90.96M 90.89M 87.63M 82.62M 79.52M 78.48M 77.44M 77.17M 73.3M 72.48M 69.25M 66.57M
Shares Outstanding (Diluted)
92.07M 91.88M 91.43M 91.36M 91.3M 91M 90.96M 90.89M 87.63M 82.62M 79.52M 78.48M 77.44M 77.17M 73.3M 72.48M 69.25M 66.57M
EPS (Basic)
-1.36 -1.1 0.28 -1.36 -0.2 -0.66 -1.6 -0.68 -2.28 -1.36 -1.7 -1.08 -2.5 -0.54 -1.2 -1.74 -1.32 -1.22
EPS (Diluted)
-1.36 -1.1 0.28 -1.36 -0.2 -0.66 -1.6 -0.68 -2.28 -1.36 -1.7 -1.08 -2.5 -0.54 -1.2 -1.74 -1.32 -1.22
EBITDA
-114.12M -88.87M 52.46M -109.91M -7.12M -48.59M -135.64M -51.65M -193.65M -106.86M -125.61M -81.56M -191.43M -31.08M -87.73M -121.69M -88.18M -80.86M
EBIT
-120M -94.07M 45.66M -115.38M -12.49M -54.31M -140.99M -56.82M -193.65M -106.86M -130.86M -81.56M -191.43M -31.08M -87.73M -125.18M -91.53M -94.56M
Depreciation & Amortization
5.87M 5.2M 6.8M 5.47M 5.37M 5.72M 5.35M 5.17M n/a 5.18M 5.25M 5.11M 4.11M 3.93M 3.71M 3.5M 3.35M 3.68M